微创活检技术市场－全球产业规模、份额、趋势、机会和预测，按产品、技术、循环生物标记、应用、最终用户、地区和竞争格局细分，2020-2030年预测

2024年全球微创切片技术市场规模为137.5亿美元，预计2030年将以10.30%的复合年增长率成长至247.6亿美元。微创切片技术是指与传统手术切片相比，在减少物理创伤、缩短恢復时间和降低併发症风险的同时，取得组织或体液样本的诊断程序。推动该市场成长的关键因素包括：全球癌症和其他需要明确组织诊断的疾病发生率不断上升；患者越来越倾向于选择创伤性较小的医疗干预措施；以及影像引导和设备精度方面的持续技术进步。这些创新提高了样本采集的准确性和效率，从而支持更广泛的临床应用。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球微创切片技术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（测试、试剂盒及耗材、仪器）
  • 按技术分类（液体活检、光学活检、刷取活检、色素性病变检测、其他）
  • 透过循环生物标记（循环肿瘤细胞 (CTC)、游离 DNA (cfDNA)、循环肿瘤 DNA (ctDNA)、细胞外囊泡、其他）
  • 依应用领域（临床、治疗）
  • 依最终使用者（医院和诊所、门诊中心、学术和研究机构）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美微创切片技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲微创切片技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区微创切片技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲微创切片技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲微创切片技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球微创切片技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Guardant Health, Inc.
• Veracyte, Inc.
• Myriad Genetics, Inc.
• Biocept, Inc.
• NeoGenomics Laboratories, Inc.
• Adaptive Biotechnologies Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Minimally Invasive Biopsy Techniques Market, valued at USD 13.75 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 24.76 Billion by 2030. Minimally invasive biopsy techniques involve diagnostic procedures designed to obtain tissue or fluid samples with reduced physical trauma, shorter recovery times, and decreased complication risks compared to conventional surgical biopsies. Key drivers propelling this market's growth include the rising global prevalence of cancer and other conditions necessitating definitive tissue diagnosis, an increasing patient inclination towards less invasive medical interventions, and continuous technological advancements in imaging guidance and device precision. These innovations enhance the accuracy and efficiency of sample collection, supporting broader clinical

Key Market Drivers

The increasing global burden of cancer and chronic diseases stands as a primary catalyst for the expansion of the minimally invasive biopsy techniques market. As diagnostic needs escalate for a growing patient population, the imperative for accurate and timely tissue sampling intensifies. These techniques offer a less intrusive yet highly effective method for obtaining critical diagnostic information, directly responding to the rising disease prevalence. According to the World Health Organization (WHO), on February 1, 2024, in "Global cancer burden growing, amidst mounting need for services," there were an estimated 20 million new cancer cases globally in 2022, underscoring the vast and continuous demand for robust diagnostic interventions. This widespread incidence drives healthcare systems to prioritize efficient and patient-friendly diagnostic pathways.

Key Market Challenges

The inherent technical complexity and demanding learning curve associated with specialized minimally invasive biopsy procedures represent a significant challenge to the growth of the Global Minimally Invasive Biopsy Techniques Market. These procedures require extensive training and substantial expertise from healthcare professionals to ensure optimal diagnostic yield and patient safety. This stringent requirement limits the number of practitioners qualified to perform these advanced techniques, directly impeding broader clinical adoption.

Key Market Trends

Liquid biopsy dominance and expansion represents a pivotal trend reshaping cancer diagnostics by offering minimally invasive methods for disease detection and surveillance. These blood-based tests analyze circulating tumor DNA and other biomarkers, providing a less intrusive alternative to conventional tissue biopsies, especially beneficial for inaccessible tumors or for continuous monitoring of treatment efficacy. The Association for Molecular Pathology and the College of American Pathologists collectively published 13 best practice recommendations for validating and reporting clinical circulating tumor DNA assays, indicating a growing formalization and clinical acceptance of these techniques in October 2023. This advancement facilitates earlier detection of recurrence and precise assessment of therapeutic response.

Key Market Players

• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Guardant Health, Inc.
• Veracyte, Inc.
• Myriad Genetics, Inc.
• Biocept, Inc.
• NeoGenomics Laboratories, Inc.
• Adaptive Biotechnologies Corporation

Report Scope:

In this report, the Global Minimally Invasive Biopsy Techniques Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Minimally Invasive Biopsy Techniques Market, By Product Offered:

• Tests
• Kits & Consumables
• Instruments

Minimally Invasive Biopsy Techniques Market, By Technique:

• Liquid Biopsy
• Optical Biopsy
• Brush Biopsy
• Pigmented Lesion Assays
• Others

Minimally Invasive Biopsy Techniques Market, By Circulating Biomarker:

• Circulating Tumor Cells (CTCs)
• Cell Free DNA (cfDNA)
• Circulating Tumor DNA (ctDNA)
• Extracellular Vesicles
• Others

Minimally Invasive Biopsy Techniques Market, By Application:

• Clinical
• Therapeutic

Minimally Invasive Biopsy Techniques Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Center
• Academic & Research Institutions

Minimally Invasive Biopsy Techniques Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Minimally Invasive Biopsy Techniques Market.

Available Customizations:

Global Minimally Invasive Biopsy Techniques Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Biopsy Techniques Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Offered (Tests, Kits & Consumables, Instruments)
  • 5.2.2. By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others)
  • 5.2.3. By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others)
  • 5.2.4. By Application (Clinical, Therapeutic)
  • 5.2.5. By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Minimally Invasive Biopsy Techniques Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Offered
  • 6.2.2. By Technique
  • 6.2.3. By Circulating Biomarker
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Offered
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Circulating Biomarker
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Offered
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Circulating Biomarker
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Minimally Invasive Biopsy Techniques Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Offered
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Circulating Biomarker
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Minimally Invasive Biopsy Techniques Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Offered
  • 7.2.2. By Technique
  • 7.2.3. By Circulating Biomarker
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Offered
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Circulating Biomarker
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Offered
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Circulating Biomarker
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Offered
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Circulating Biomarker
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Offered
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Circulating Biomarker
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Minimally Invasive Biopsy Techniques Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Offered
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Circulating Biomarker
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Minimally Invasive Biopsy Techniques Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Offered
  • 8.2.2. By Technique
  • 8.2.3. By Circulating Biomarker
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Offered
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Circulating Biomarker
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Offered
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Circulating Biomarker
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Offered
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Circulating Biomarker
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Offered
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Circulating Biomarker
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Minimally Invasive Biopsy Techniques Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Offered
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Circulating Biomarker
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Minimally Invasive Biopsy Techniques Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Offered
  • 9.2.2. By Technique
  • 9.2.3. By Circulating Biomarker
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Offered
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Circulating Biomarker
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Offered
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Circulating Biomarker
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Minimally Invasive Biopsy Techniques Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Offered
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Circulating Biomarker
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Minimally Invasive Biopsy Techniques Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Offered
  • 10.2.2. By Technique
  • 10.2.3. By Circulating Biomarker
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Offered
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Circulating Biomarker
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Offered
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Circulating Biomarker
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Minimally Invasive Biopsy Techniques Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Offered
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Circulating Biomarker
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Minimally Invasive Biopsy Techniques Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. PerkinElmer Inc.
• 15.4. QIAGEN NV
• 15.5. Guardant Health, Inc.
• 15.6. Veracyte, Inc.
• 15.7. Myriad Genetics, Inc.
• 15.8. Biocept, Inc.
• 15.9. NeoGenomics Laboratories, Inc.
• 15.10. Adaptive Biotechnologies Corporation

16. Strategic Recommendations

17. About Us & Disclaimer